These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34990700)

  • 41. A ROS-Responsive Self-Assembly Driven by Multiple Intermolecular Interaction Enhances Tumor-Targeted Chemotherapy.
    Xiong Y; Yang G; Zhou H; Li W; Sun J; Tao T; Li J
    J Pharm Sci; 2021 Apr; 110(4):1668-1675. PubMed ID: 33198946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug Delivery System for Refractory Cancer Therapy via an Endogenous Albumin Transport System.
    Ishima Y; Maruyama T; Otagiri M; Ishida T
    Chem Pharm Bull (Tokyo); 2020; 68(7):583-588. PubMed ID: 32611995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
    Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
    Li Y; Hou H; Zhang P; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
    Xiong XB; Ma Z; Lai R; Lavasanifar A
    Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
    Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
    Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel self-assembly albumin nanocarrier for reducing doxorubicin-mediated cardiotoxicity.
    Yuan A; Wu J; Song C; Tang X; Qiao Q; Zhao L; Gong G; Hu Y
    J Pharm Sci; 2013 May; 102(5):1626-35. PubMed ID: 23423631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparan sulfate targeting strategy for enhancing liposomal drug accumulation and facilitating deep distribution in tumors.
    Kuo PH; Teng YH; Cin AL; Han W; Huang PW; Wang LH; Chou YT; Yang JL; Tseng YL; Kao M; Chang MD
    Drug Deliv; 2020 Dec; 27(1):542-555. PubMed ID: 32241176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
    Haque ST; Islam RA; Gan SH; Chowdhury EH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
    [No Abstract]   [Full Text] [Related]  

  • 51. Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
    Xu W; Lou Y; Chen W; Kang Y
    Biomed Tech (Berl); 2020 Apr; 65(2):229-236. PubMed ID: 31605575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response of pH-Sensitive Doxorubicin Nanoparticles on Complex Tumor Microenvironments by Tailoring Multiple Physicochemical Properties.
    Chen H; Luo Q; Wang J; He H; Luo W; Zhang L; Xiao Q; Chen T; Xu X; Niu W; Ke Y; Wang Y
    ACS Appl Mater Interfaces; 2020 May; 12(20):22673-22686. PubMed ID: 32337980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biosynthesis of flower-shaped Au nanoclusters with EGCG and their application for drug delivery.
    Wu S; Yang X; Luo F; Wu T; Xu P; Zou M; Yan J
    J Nanobiotechnology; 2018 Nov; 16(1):90. PubMed ID: 30424776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment.
    Wang S; Zhou X; Zeng Z; Sui M; Chen L; Feng C; Huang C; Yang Q; Ji M; Hou P
    J Nanobiotechnology; 2021 Oct; 19(1):302. PubMed ID: 34600560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
    Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model.
    Rudnick-Glick S; Corem-Salkmon E; Grinberg I; Margel S
    J Nanobiotechnology; 2016 Dec; 14(1):80. PubMed ID: 27919267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes.
    Kinoshita R; Ishima Y; Ikeda M; Kragh-Hansen U; Fang J; Nakamura H; Chuang VT; Tanaka R; Maeda H; Kodama A; Watanabe H; Maeda H; Otagiri M; Maruyama T
    J Control Release; 2015 Nov; 217():1-9. PubMed ID: 26302904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. iRGD-decorated reduction-responsive nanoclusters for targeted drug delivery.
    Hu H; Wan J; Huang X; Tang Y; Xiao C; Xu H; Yang X; Li Z
    Nanoscale; 2018 Jun; 10(22):10514-10527. PubMed ID: 29799599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative and Injectable Preformed Albumin-Bound Anticancer Drug Delivery System for Anticancer and Antimetastasis Treatment.
    Zhou C; Song X; Guo C; Tan Y; Zhao J; Yang Q; Chen D; Tan T; Sun X; Gong T; Zhang Z
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):42534-42548. PubMed ID: 31479235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.